CHARMD

Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database


  • TOP

    Filociclovir

    Assays:

    Mutant Gene Type Virus EC50 ratio Phenotype Assay Reference
    M460I UL97 SNP Human betaherpesvirus 5 12.00 High level resistance Details Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. (Jan 2011)
    M460V UL97 SNP Human betaherpesvirus 5 4.00 Intermediate level resistance Details Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. (Jan 2011)
    H520Q UL97 SNP Human betaherpesvirus 5 5.00-20.00 Range of values of High level resistance Details Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. (Jan 2011)
    C592G UL97 SNP Human betaherpesvirus 5 2.20-4.90 Range of values between Low level resistance and Intermediate level resistance Details Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020)
    A594V UL97 SNP Human betaherpesvirus 5 2.20-4.90 Range of values between Low level resistance and Intermediate level resistance Details Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020)
    L595S UL97 SNP Human betaherpesvirus 5 <2.20 No more than Low level resistance Details Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020)
    C603W UL97 SNP Human betaherpesvirus 5 2.20-4.90 Range of values between Low level resistance and Intermediate level resistance Details Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance. (Apr 2020)


    Tilloy et al., 2024
    Interdeposit Digital Number: IDDN.FR.001.420004.000.S.X.2024.000.31230